Literature DB >> 22671426

Role of adrenal glucocorticoid signaling in prefrontal cortex gene expression and acute behavioral responses to ethanol.

Blair N Costin1, Aaron R Wolen, Sylvia Fitting, Keith L Shelton, Michael F Miles.   

Abstract

BACKGROUND: Glucocorticoid hormones modulate acute and chronic behavioral and molecular responses to drugs of abuse including psychostimulants and opioids. There is growing evidence that glucocorticoids might also modulate behavioral responses to ethanol ( EtOH ). Acute EtOH activates the hypothalamic-pituitary-adrenal axis, causing the release of adrenal glucocorticoid hormones. Our prior genomic studies suggest that glucocorticoids play a role in regulating gene expression in the prefrontal cortex (PFC) of DBA2/J (D2) mice following acute EtOH administration. However, few studies have analyzed the role of glucocorticoid signaling in behavioral responses to acute EtOH . Such work could be significant, given the predictive value for the level of response to acute EtOH in the risk for alcoholism.
METHODS: We studied whether the glucocorticoid receptor (GR) antagonist, RU-486, or adrenalectomy (ADX) altered male D2 mouse behavioral responses to acute (locomotor activation, anxiolysis, or loss-of-righting reflex [LORR]) or repeated (sensitization) EtOH treatment. Whole-genome microarray analysis and bioinformatics approaches were used to identify PFC candidate genes possibly responsible for altered behavioral responses to EtOH following ADX.
RESULTS: ADX and RU-486 both impaired acute EtOH (2 g/kg)-induced locomotor activation in D2 mice without affecting basal locomotor activity. However, neither ADX nor RU-486 altered the initiation of EtOH sensitization (locomotor activation or jump counts), EtOH -induced anxiolysis, or LORR. ADX mice showed microarray gene expression changes in PFC that significantly overlapped with acute EtOH -responsive gene sets derived by our prior microarray studies. Q-rtPCR analysis verified that ADX decreased PFC expression of Fkbp5 while significantly increasing Gpr6 expression. In addition, high-dose RU-486 pretreatment blunted EtOH -induced Fkbp5 expression.
CONCLUSIONS: Our studies suggest that EtOH 's activation of adrenal glucocorticoid release and subsequent GR activation may partially modulate EtOH 's acute locomotor activation in male D2 mice. Furthermore, because adrenal glucocorticoid basal tone regulated PFC gene expression, including a significant set of acute EtOH -responsive genes, this suggests that glucocorticoid-regulated PFC gene expression may be an important factor modulating acute behavioral responses to EtOH .
Copyright © 2012 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22671426      PMCID: PMC3507324          DOI: 10.1111/j.1530-0277.2012.01841.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  38 in total

1.  Acute sensitivity of FAST and SLOW mice to the effects of abused drugs on locomotor activity.

Authors:  T J Phillips; S Burkhart-Kasch; C C Gwiazdon; J C Crabbe
Journal:  J Pharmacol Exp Ther       Date:  1992-05       Impact factor: 4.030

Review 2.  Glucocorticoids and glucocorticoid antagonists: lessons from RU 486.

Authors:  G P Chrousos; L Laue; L K Nieman; S Kawai; R U Udelsman; D D Brandon; D L Loriaux
Journal:  Kidney Int Suppl       Date:  1988-10       Impact factor: 10.545

3.  Circulating adrenal hormones are not necessary for the development of sensitization to the psychomotor activating effects of amphetamine.

Authors:  A Badiani; M I Morano; H Akil; T E Robinson
Journal:  Brain Res       Date:  1995-02-27       Impact factor: 3.252

4.  Modulation of the locomotor response to amphetamine by corticosterone.

Authors:  M Cador; J Dulluc; P Mormède
Journal:  Neuroscience       Date:  1993-10       Impact factor: 3.590

5.  Adrenalectomy reduces alcohol-stimulated activity: blood and brain alcohol content.

Authors:  C J Wallis; R F Anton; C L Randall
Journal:  Pharmacol Biochem Behav       Date:  1984-06       Impact factor: 3.533

6.  Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics.

Authors:  G S Wand; A S Dobs
Journal:  J Clin Endocrinol Metab       Date:  1991-06       Impact factor: 5.958

7.  Low level of response to alcohol as a predictor of future alcoholism.

Authors:  M A Schuckit
Journal:  Am J Psychiatry       Date:  1994-02       Impact factor: 18.112

8.  Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization.

Authors:  A J Roberts; C N Lessov; T J Phillips
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

9.  Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion.

Authors:  V Deroche; M Marinelli; S Maccari; M Le Moal; H Simon; P V Piazza
Journal:  J Neurosci       Date:  1995-11       Impact factor: 6.167

10.  Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines.

Authors:  J Crawley; F K Goodwin
Journal:  Pharmacol Biochem Behav       Date:  1980-08       Impact factor: 3.533

View more
  10 in total

1.  The allostatic impact of chronic ethanol on gene expression: A genetic analysis of chronic intermittent ethanol treatment in the BXD cohort.

Authors:  Andrew D van der Vaart; Jennifer T Wolstenholme; Maren L Smith; Guy M Harris; Marcelo F Lopez; Aaron R Wolen; Howard C Becker; Robert W Williams; Michael F Miles
Journal:  Alcohol       Date:  2016-11-01       Impact factor: 2.405

2.  Effects of selection for ethanol preference on gene expression in the nucleus accumbens of HS-CC mice.

Authors:  A M Colville; O D Iancu; D L Oberbeck; P Darakjian; C L Zheng; N A R Walter; C A Harrington; R P Searles; S McWeeney; R J Hitzemann
Journal:  Genes Brain Behav       Date:  2017-02-09       Impact factor: 3.449

3.  The Prefrontal Cortex as a Critical Gate of Negative Affect and Motivation in Alcohol Use Disorder.

Authors:  Amanda R Pahng; M Adrienne McGinn; Rod I Paulsen; Scott Edwards
Journal:  Curr Opin Behav Sci       Date:  2017-02

4.  Analyses of differentially expressed genes after exposure to acute stress, acute ethanol, or a combination of both in mice.

Authors:  Jessica A Baker; Jingxin Li; Diana Zhou; Ming Yang; Melloni N Cook; Byron C Jones; Megan K Mulligan; Kristin M Hamre; Lu Lu
Journal:  Alcohol       Date:  2016-12-16       Impact factor: 2.405

5.  Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol.

Authors:  P S S Rao; Hannah Saternos; Sunil Goodwani; Youssef Sari
Journal:  Psychopharmacology (Berl)       Date:  2015-01-27       Impact factor: 4.530

6.  Ethanol regulation of serum glucocorticoid kinase 1 expression in DBA2/J mouse prefrontal cortex.

Authors:  Blair N Costin; Seth M Dever; Michael F Miles
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

7.  Ethanol-Induced Behavioral Sensitization Alters the Synaptic Transcriptome and Exon Utilization in DBA/2J Mice.

Authors:  Megan A O'Brien; Rory M Weston; Nihar U Sheth; Steven Bradley; John Bigbee; Ashutosh Pandey; Robert W Williams; Jennifer T Wolstenholme; Michael F Miles
Journal:  Front Genet       Date:  2018-09-24       Impact factor: 4.599

Review 8.  The Role of the Lateral Hypothalamus in Violent Intraspecific Aggression-The Glucocorticoid Deficit Hypothesis.

Authors:  József Haller
Journal:  Front Syst Neurosci       Date:  2018-06-08

9.  The role of the glucocorticoids in developing resilience to stress and addiction.

Authors:  Subhashini Srinivasan; Masroor Shariff; Selena E Bartlett
Journal:  Front Psychiatry       Date:  2013-08-01       Impact factor: 4.157

10.  Intermittent Ethanol during Adolescence Leads to Lasting Behavioral Changes in Adulthood and Alters Gene Expression and Histone Methylation in the PFC.

Authors:  Jennifer T Wolstenholme; Tariq Mahmood; Guy M Harris; Shahroze Abbas; Michael F Miles
Journal:  Front Mol Neurosci       Date:  2017-09-26       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.